Mostrar el registro sencillo del ítem

dc.contributor.author
Boni, Silvia  
dc.contributor.author
Marin, Gustavo Horacio  
dc.contributor.author
Campaña, Laura  
dc.contributor.author
Marin, Lupe  
dc.contributor.author
Marin, G.  
dc.contributor.author
Risso Patron, Soledad  
dc.contributor.author
Gabriel, Fernanda  
dc.contributor.author
Corso, Alejandra  
dc.contributor.author
Garay, Valeria  
dc.contributor.author
Limeres, Manuel  
dc.date.available
2023-02-16T13:52:44Z  
dc.date.issued
2022-02  
dc.identifier.citation
Boni, Silvia; Marin, Gustavo Horacio; Campaña, Laura; Marin, Lupe; Marin, G.; et al.; Correlation of Watch Antibiotic Consumption with a Gram-negative Bacteria Resistance: Analysis at a Country Level; Galenos Publishing House; Mediterranean Journal of Infection, Microbes and Antimicrobials; 10; 67; 2-2022; 1-9  
dc.identifier.uri
http://hdl.handle.net/11336/188260  
dc.description.abstract
Introduction: Bacterial antimicrobial resistance (AMR) to the antibiotics (ATB) has severe consequences for human health. The excess ATB consumption is one of the main causes of AMR. One of the World Health Organizations main objective in AMR control strategy is to limit the ATB irrational use, that is why, it proposed to classify the ATB in three groups: “Access”, “Watch”, and “Reserve”, being the latter two preserved for certain situations. The present work aims to know the level of ATB consumption and its correlation with the Gram-negative resistance in Argentina. Materials and Methods: Gram-negative bacteria resistance to “watch” the ATB groups (cephalosporins/carbapenem/fluoroquinolones) were explored for Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Antibiotic consumption was expressed by the defined daily dose/1000 inhabitants for each ATB for one year period (2018). Resistance/consumption ratio was obtained by calculating the “R” for each region of the country, comparing them with the other countries. Results: E. coli resistance to 3rd generation cephalosporines was 8.68% and 16.51% in urine (U) and blood (B) samples, respectively, while to carbapenems was 0.08% (U) and 0.36% (B). Resistance of K. pneumoniae to 3 GC was 39.78% (U) and 52.45% (B) while to carbapenem was 9.03% (U) and 17.46% (B). P. aeruginosa resistance to fluoroquinolone and to carbapenems was 29.7% (U)/26.4% (B) and 17.7% (U)/19.9% (B), respectively. The resistance/consumption ratio was heterogenous within the country. Most of the populated areas patterns had similarities with the one observed in the less developed countries (mild-high resistance/mild-high consumption), while the ratio found in less densely populated areas, mimicked countries with the most rational use of ATB. Conclusion: In Argentina, Gram-negative bacteria showed overall high/mild resistance levels against the “Watch” ATB groups, with a largely variations among each region.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Galenos Publishing House  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
ANTIMICROBIALS  
dc.subject
WATCH  
dc.subject
RESISTANCE  
dc.subject
ARGENTINA  
dc.subject.classification
Políticas y Servicios de Salud  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Correlation of Watch Antibiotic Consumption with a Gram-negative Bacteria Resistance: Analysis at a Country Level  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2023-02-09T15:47:49Z  
dc.identifier.eissn
2147-673X  
dc.journal.volume
10  
dc.journal.number
67  
dc.journal.pagination
1-9  
dc.journal.pais
Turquía  
dc.journal.ciudad
Estambul  
dc.description.fil
Fil: Boni, Silvia. Ministerio de Salud. Administración Nacional de Medicamentos, Alimentos y Tecnología Médica; Argentina  
dc.description.fil
Fil: Marin, Gustavo Horacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Ministerio de Salud. Administración Nacional de Medicamentos, Alimentos y Tecnología Médica; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Médicas; Argentina  
dc.description.fil
Fil: Campaña, Laura. Ministerio de Salud. Administración Nacional de Medicamentos, Alimentos y Tecnología Médica; Argentina  
dc.description.fil
Fil: Marin, Lupe. Universidad Nacional de La Plata. Facultad de Ciencias Médicas; Argentina  
dc.description.fil
Fil: Marin, G.. Universidad Nacional de La Plata. Facultad de Ciencias Médicas; Argentina  
dc.description.fil
Fil: Risso Patron, Soledad. Ministerio de Salud. Administración Nacional de Medicamentos, Alimentos y Tecnología Médica; Argentina  
dc.description.fil
Fil: Gabriel, Fernanda. Ministerio de Salud. Administración Nacional de Medicamentos, Alimentos y Tecnología Médica; Argentina  
dc.description.fil
Fil: Corso, Alejandra. Ministerio de Salud. Administración Nacional de Medicamentos, Alimentos y Tecnología Médica; Argentina  
dc.description.fil
Fil: Garay, Valeria. Ministerio de Salud. Administración Nacional de Medicamentos, Alimentos y Tecnología Médica; Argentina  
dc.description.fil
Fil: Limeres, Manuel. Ministerio de Salud. Administración Nacional de Medicamentos, Alimentos y Tecnología Médica; Argentina  
dc.journal.title
Mediterranean Journal of Infection, Microbes and Antimicrobials  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencegate.app/document/10.4274/mjima.galenos.2021.2021.67  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.4274/mjima.galenos.2021.2021.67